Orser Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,982
| Closed | -$2.1M | – | 50 |
|
|
2025
Q1 | $2.1M | Buy |
+28,982
| New | +$2.1M | 1.54% | 19 |
|
|
2023
Q2 | – | Sell |
-43,461
| Closed | -$3.6M | – | 54 |
|
|
2023
Q1 | $3.6M | Buy |
+43,461
| New | +$3.6M | 4.05% | 6 |
|
|
2021
Q3 | – | Sell |
-45,135
| Closed | -$4.68M | – | 92 |
|
|
2021
Q2 | $4.68M | Buy |
+45,135
| New | +$4.68M | 2.41% | 8 |
|
|
2021
Q1 | – | Sell |
-47,875
| Closed | -$4.37M | – | 89 |
|
|
2020
Q4 | $4.37M | Buy |
+47,875
| New | +$4.37M | 2.77% | 9 |
|
|
2020
Q2 | – | Sell |
-42,573
| Closed | -$2.68M | – | 62 |
|
|
2020
Q1 | $2.68M | Buy |
42,573
+390
| +0.9% | +$24.5K | 3.77% | 6 |
|
|
2019
Q4 | $3.27M | Buy |
+42,183
| New | +$3.27M | 3.17% | 7 |
|
|
2019
Q1 | – | Sell |
-39,330
| Closed | -$1.93M | – | 70 |
|
|
2018
Q4 | $1.93M | Buy |
+39,330
| New | +$1.93M | 2.23% | 15 |
|
|
2018
Q3 | – | Sell |
-41,640
| Closed | -$2.05M | – | 88 |
|
|
2018
Q2 | $2.05M | Sell |
41,640
-3,468
| -8% | -$170K | 1.78% | 15 |
|
|
2018
Q1 | $2.05M | Buy |
45,108
+3,378
| +8% | +$153K | 1.9% | 12 |
|
|
2017
Q4 | $1.7M | Buy |
+41,730
| New | +$1.7M | 1.51% | 25 |
|